Search results
Results from the WOW.Com Content Network
St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. [4] [5] St. Jude Medical's bi-leaflet valve was developed in large part by Dr. Demetre Nicoloff of the University of Minnesota and St. Jude Medical employee Don Hanson.
Guidant Corporation, part of Boston Scientific and Abbott Labs, designs and manufactures artificial cardiac pacemakers, implantable cardioverter-defibrillators, stents, and other cardiovascular medical products. Their company headquarters is located in Indianapolis, Indiana.
Syngenta rejecteded another unsolicited offer from Monsanto, worth $45 billion, with management saying it undervalued the company and a merger would carry significant risks. Monsanto offered to acquire the company at a price of 449 Swiss francs per Syngenta share, with approximately 45% of the price paid in cash.
For premium support please call: 800-290-4726 more ways to reach us
St. Jude Medical (NYS: STJ) carries $3.9 billion of goodwill and other intangibles on its balance sheet. Sometimes goodwill, especially when it's excessive, can foreshadow problems down the road.
Margins matter. The more St. Jude Medical (NYS: STJ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.
Transaction values are given in the US dollar value for the year of the merger, ... Abbott Laboratories: St Jude Medical: 25.0 — 30.5: 31.7 — 38.7 [314] 65 2019:
Ford joined Abbott in 1996 within its diabetes care business, later heading the company's medical device businesses, and Abbott's integration of St. Jude Medical in 2017, its largest acquisition at the time. [3] [4] He was named President and COO in October 2018. [5]